Na Shen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Top Venues

Journal of translational medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yiquan Xiong, Lan Shi, Lei Li, Wen Yang, Huiqiong Zhang, Xiangwang Zhao, Na Shen
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1. Journal of translational medicine 22 (1) (2024)
Ming Luo, Na Shen, Li Shang, Zeng Fang, Ying Xin, Yuxi Ma, Min Du, Yuan Yuan, Chenchen Hu, Yun Tang, Jing Huang, Wei Wei, Myung Ryul Lee, Paul J Hergenrother, Max S Wicha
Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling. Cancer research (2024)
Yiquan Xiong, Lan Shi, Lei Li, Wen Yang, Huiqiong Zhang, Xiangwang Zhao, Na Shen
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1. Journal of translational medicine 22 (1) (2024)
Yiquan Xiong, Lan Shi, Lei Li, Wen Yang, Huiqiong Zhang, Xiangwang Zhao, Na Shen
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1. Journal of translational medicine 22 (1) (2024)
Yiquan Xiong, Lan Shi, Lei Li, Wen Yang, Huiqiong Zhang, Xiangwang Zhao, Na Shen
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1. Journal of translational medicine 22 (1) (2024)